24 results
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
price of any Warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and expenses incident to our
8-K
EX-10.2
vyr8i7cjp4n8vt5
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
POS AM
s7clgtzkfnids6j
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
424B3
4l8ckjjrd6l9y
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-10.1
ls8a bcul
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B3
yh81mxzyo zs
20 Dec 21
Prospectus supplement
7:24am
8-K
EX-10.1
44j4zu
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B3
lqxo0b60tylpdfmm9
23 Nov 21
Prospectus supplement
4:11pm
S-1
ij7 cysbjqq
12 Nov 21
IPO registration
5:03pm
8-K
EX-10.1
omfo n9u9t2x
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
10-K
hkw 1jjrcu8g9a1gpr9
31 Mar 21
Annual report
4:30pm
8-K
EX-3.2
2wv5xc
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am